hydralazine has been researched along with Death, Sudden, Cardiac in 4 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Death, Sudden, Cardiac: Unexpected rapid natural death due to cardiovascular collapse within one hour of initial symptoms. It is usually caused by the worsening of existing heart diseases. The sudden onset of symptoms, such as CHEST PAIN and CARDIAC ARRHYTHMIAS, particularly VENTRICULAR TACHYCARDIA, can lead to the loss of consciousness and cardiac arrest followed by biological death. (from Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th ed., 2005)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Male patients aged 18-75 years with chronic heart failure were randomized to enalapril or hydralazine-isosorbide dinitrate." | 9.07 | Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure. The V-HeFT II VA Cooperative Studies Group. ( Carson, P; Cintron, GB; Cohn, JN; Fletcher, RD; Johnson, G; Orndorff, J, 1993) |
| "Male patients aged 18-75 years with chronic heart failure were randomized to enalapril or hydralazine-isosorbide dinitrate." | 5.07 | Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure. The V-HeFT II VA Cooperative Studies Group. ( Carson, P; Cintron, GB; Cohn, JN; Fletcher, RD; Johnson, G; Orndorff, J, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sandhu, AT | 1 |
| Kohsaka, S | 1 |
| Turakhia, MP | 1 |
| Lewis, EF | 1 |
| Heidenreich, PA | 1 |
| Lee, TH | 1 |
| Hamilton, MA | 1 |
| Stevenson, LW | 1 |
| Moriguchi, JD | 1 |
| Fonarow, GC | 1 |
| Child, JS | 1 |
| Laks, H | 1 |
| Walden, JA | 1 |
| Goldman, S | 1 |
| Johnson, G | 2 |
| Cohn, JN | 2 |
| Cintron, G | 1 |
| Smith, R | 1 |
| Francis, G | 1 |
| Fletcher, RD | 1 |
| Cintron, GB | 1 |
| Orndorff, J | 1 |
| Carson, P | 1 |
2 trials available for hydralazine and Death, Sudden, Cardiac
| Article | Year |
|---|---|
Mechanism of death in heart failure. The Vasodilator-Heart Failure Trials. The V-HeFT VA Cooperative Studies Group.
Topics: Cause of Death; Death, Sudden, Cardiac; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; | 1993 |
Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure. The V-HeFT II VA Cooperative Studies Group.
Topics: Death, Sudden, Cardiac; Drug Therapy, Combination; Electrocardiography, Ambulatory; Enalapril; Heart | 1993 |
2 other studies available for hydralazine and Death, Sudden, Cardiac
| Article | Year |
|---|---|
Evaluation of Quality of Care for US Veterans With Recent-Onset Heart Failure With Reduced Ejection Fraction.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Aminobutyrates; Angiotensin Receptor Antagonis | 2022 |
Impact of left ventricular cavity size on survival in advanced heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Body Constitution; Cause of Death; Cohort Studies; Death, | 1993 |